http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#Head
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#assertion
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#provenance
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#pubinfo
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#assertion
http://purl.obolibrary.org/obo/DOID_1339
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_1339
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB01234
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#association
http://www.w3.org/2000/01/rdf-schema#label
allergic states control of severe or incapacitating allergic conditions intractable to adequate trials of conventional treatment in asthma atopic dermatitis contact dermatitis drug hypersensitivity reactions perennial or seasonal allergic rhinitis and serum sickness dermatologic diseases bullous dermatitis herpetiformis exfoliative erythroderma mycosis fungoides pemphigus and severe erythema multiforme stevens johnson syndrome endocrine disorders primary or secondary adrenocortical insufficiency hydrocortisone or cortisone is the drug of choice may be used in conjunction with synthetic mineralocorticoid analogs where applicable in infancy mineralocorticoid supplementation is of particular importance congenital adrenal hyperplasia hypercalcemia associated with cancer and nonsuppurative thyroiditis gastrointestinal diseases to tide the patient over a critical period of the disease in regional enteritis and ulcerative colitis hematologic disorders acquired autoimmune hemolytic anemia congenital erythroid hypoplastic anemia diamond blackfan anemia idiopathic thrombocytopenic purpura in adults pure red cell aplasia and selected cases of secondary thrombocytopenia miscellaneous diagnostic testing of adrenocortical hyperfunction trichinosis with neurologic or myocardial involvement tuberculous meningitis with subarachnoid block or impending block when used with appropriate antituberculous chemotherapy neoplastic diseases for the palliative management of leukemias and lymphomas nervous system acute exacerbations of multiple sclerosis cerebral edema associated with primary or metastatic brain tumor craniotomy or head injury ophthalmic diseases sympathetic ophthalmia temporal arteritis uveitis and ocular inflammatory conditions unresponsive to topical corticosteroids renal diseases to induce a diuresis or remission of proteinuria in idiopathic nephrotic syndrome or that due to lupus erythematosus respiratory diseases berylliosis fulminating or disseminated pulmonary tuberculosis when used concurrently with appropriate antituberculous chemotherapy idiopathic eosinophilic pneumonias symptomatic sarcoidosis rheumatic disorders as adjunctive therapy for short term administration to tide the patient over an acute episode or exacerbation in acute gouty arthritis acute rheumatic carditis ankylosing spondylitis psoriatic arthritis rheumatoid arthritis including juvenile rheumatoid arthritis selected cases may require low dose maintenance therapy for the treatment of dermatomyositis polymyositis and systemic lupus erythematosus
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB01234
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#provenance
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#pubinfo
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#sig
http://purl.org/nanopub/x/hasSignature
JddVUWydStkVCxK3HuAlUQtfpNqF5vKYG5f/2jKqCNnIy/bHhE3iAvqgdlvAmBEIqxM3oLTHOMnxVY11SjsCyhaHmjSa6iwm6b+ABOaFZBs6XD2mmrXYW3RW1of9MGqhAJZt2pBVd5l/6JOeJGxjb2nyU8YMeJKYjjyFoMPIHww=
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw
http://purl.org/dc/terms/created
2021-07-03T11:50:33.650+02:00
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAW6OMiMBpBa8iPcRjXWLhDasleG9_v4mMPv2Wyr0w2kw
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs